Agile Therapeutics

Wanting To Invest In Agile Therapeutics Inc.: Understand The Market Performance

ankara escort balgat escort çankaya escort çebeci escort demetevler escort dikmen escort eryaman escort esat escort etlik escort keçiören escort kızılay escort kolej escort rus escort sincan escort yenimahalle escort alanya escort

There are various pharmaceuticals and therapeutics firms that are fighting to get to the front of the industry chart. The main reason is the need for medicines and drugs and proper treatment for some of the unmet diseases on a global level. But currently, the wobbly market conditions and uncertainty among the investors are causing stock downfall. So if one is planning g to invest in Agile Therapeutics Inc. then, giving a detailed study of the agrx stock at performance and fundamentals is a must. 

bostancı escort ataşehir escort kadıköy escort bayan ataşehir escort kartal escort tuzla escort pendik escort bostancı escort anadolu yakası escort göztepe escort alanya escort

Stock performance

Currently, Agile Therapeutics Inc. is falling in its price, as it hit a down of -0.35%. But it also recorded a one-week price increase, which was recorded as more than 2.91%. The current trading rating of Agile Therapeutics Inc. is bullish and the average rating on the equity also stands at 1.50. 

The current market capitalization of the shares is $253.51 million, with $71.18 million current afloat shares and $76.65 million outstanding shares. The current sessions’ trading volume of the Agile Therapeutics Inc. shares was 1616766 compared to the overall average trading volume standing at 3.07 M shares. This particular data shows that Agile Therapeutics Inc. stock is now active in the stock market. 

The RSI rating of Agile Therapeutics Inc. stocks is at 62.71, which shows a buying tendency. Three-week average RSI of the stock was 58.12 and the two weeks average stood as 61.98. Also, the 50 days moving average of the agrxstock was at 2.20, the 200-day moving average is at 2.08 and last week’s average was at 2.73.

Fundamentals analysis

Without studying the fundamentals of the company, one should not think of investing it. The overall fundamentals of the firm compelling to start with. The debt to equity is at 0.38, total debt to total assets is at 0.35 and total debt to total capital is at 0.37. Also, the return on capital is -57.07 and the return on invested capital is -57.45. The return on assets stayed put at -51.73, but the return on equity slipped down to -56.45. 

The overall liquidity condition of the firm is interesting as the current ratio stands at 33.70 and the quick ration, too is at 33.70. Also, the overall employee efficiency is at -$1,240,400 per employee. 

Final words

The overall condition and performance of the company are interesting as certain numbers are on the up while some are on the decline. Overall analyst’s ratings and analysis help the investors to understand the current tradability of the shares. Maxim Group has given a target of Buy to the stocks, whereas Janney too, has given the same ratings of Buy. The price to book ratio is given a 2.40 and the price to cahs ration by each share is 1.05. Whereas the true average range for the firm is 0.26. If you want to know more stock news such as rvp stock , you can visit .

Leave a Comment